Cytokines and acute neurodegeneration
Top Cited Papers
- 1 October 2001
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 2 (10), 734-744
- https://doi.org/10.1038/35094583
Abstract
Cytokines have been implicated as mediators and inhibitors of diverse forms of neurodegeneration. They are induced in response to brain injury and have diverse actions that can cause, exacerbate, mediate and/or inhibit cellular injury and repair. Here we review evidence for the contribution of cytokines to acute neurodegeneration, focusing primarily on interleukin 1 (IL-1), tumour necrosis factor-alpha (TNFalpha) and transforming growth factor-beta (TGFbeta). TGFbeta seems to exert primarily neuroprotective actions, whereas TNFalpha might contribute to neuronal injury and exert protective effects. IL-1 mediates ischaemic, excitotoxic and traumatic brain injury, probably through multiple actions on glia, neurons and the vasculature. Understanding cytokine action in acute neurodegeneration could lead to novel and effective therapeutic strategies, some of which are already in clinical trials.Keywords
This publication has 154 references indexed in Scilit:
- TGF-β1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal culturesNeurochemistry International, 2001
- TGF-?1-dependent differential expression of a rat homolog for latent TGF-? binding protein in astrocytes and C6 glioma cellsGlia, 1999
- Expression of Fas Antigen in the Normal Mouse BrainBiochemical and Biophysical Research Communications, 1998
- Endogenous Interleukin-1 Receptor Antagonist is NeuroprotectiveBiochemical and Biophysical Research Communications, 1997
- Transforming growth factor-β1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expressionNeuroscience Letters, 1997
- Opposite effects of TGF-β1 on rapidly- and slowly-triggered excitotoxic injuryNeuropharmacology, 1996
- Tumor Necrosis Factor-α Mediates the Release of Bioactive Transforming Growth Factor-β in Murine Microglial Cell CulturesClinical Immunology and Immunopathology, 1995
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- Identification and characterization of receptors for tumor necrosis factor-α in the brainBiochemical and Biophysical Research Communications, 1991
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991